|
1.
Share Success: Letters From Readers
Letter I: From Rebecca
Received
at Testimonial Submit Form Friday, August 09, 2019 at 12:46:37
(Unedited)
Hi, my name is Rebecca.
I' m 71 and have been taking Ezorb for a couple of years for osteoporosis/osteopenia.
Every two years, my Dexa scan showed slight improvement. This week I was tested
again after two years. It showed a stunning 28% improvement!
My spine is now in the normal range! I have recommended Ezorb to others, but
this last improvement was so dramatic, I'll be talking to more people:)
Thanks for such a great product!
Letter II: From Louisa P.
Received
at sharesuccess @ ezorbonline.com Aug 20 at 11:52 PM
(Unedited)
Hi I just turned 42. My friend gifted me with a bottle of EZorb for my birthday.
What a great present!
I have Polycystic ovarian syndrome PCOS and deal with very very heavy bleeding for very long periods of time. Just wondering why this pill out of every supplement, hormone therapy, this stopped cramps and bleeding is so much better almost stopped.
I'm just curious what the calcium in this product has to do with healing my ovaries or has to do with blood clotting? I'm super marveled at the response my body has taken to this in less than a week and am beyond thankful!
***************************************************
From
the Desk of EZorb Newsletter Editor:
This
newsletter is now read by over 120,000 subscribers
worldwide. Success stories you have contributed over
the years have had a great impact on many people's
quality of life. Your continuous support will be
greatly appreciated by tens of thousands who have been
suffering and would continuously suffer, without your
help! Please email your
story to sharesuccess @ ezorbonline.com
or simply post it at Testimonial
Submit Form. Your personal information will never be
revealed to the public. We appreciate your effort. If your testimonial is selected for publication, you will receive a generous gift to show our appreciation of your effort.
2.
Research News: CGM May WorkWell for Seniors With Memory Issues
Findings from a UK feasibility study suggest that continuous glucose monitoring (CGM) is an acceptable approach for older people with diabetes and memory problems, but devices with automated transfer of glucose readings may be needed to improve completeness of data capture.
The research involved 12 hospitalized patients with an average age of 85 years who had type 1 (n=1) or type 2 (n=11) diabetes, and either a diagnosis of dementia (n=3) or an Abbreviated Mental Test score of 8 points or lower (n=9). After discharge from hospital, participants commenced GCM use with the FreeStyle Libre flash glucose monitoring device, consisting of a reader (or an app for people with certain smart phones) and a sensor.
Katharina Mattishent, from the University of East Anglia in Norwich, and team explain that although the FreeStyle Libre device measures glucose levels continuously, "data are not transmitted continuously from the sensor," and "the user has to swipe the sensor with a reader at 8 hourly intervals in order to achieve complete capture of data throughout the 2-week life-span of a sensor."
Thus, completeness of data capture by the CGM device "varied considerably," they report in BMJ Open.
Over 2 weeks, data capture ranged from 3% to 92%, with half of the participants having less than 60% of glucose readings recorded. Of the nine insulin users in the study, 66% experienced hypoglycemic events, with an average duration of 106 to 437 minutes.
The investigators say that the poor data capture in some participants was "due to the need for users to conduct more than 3 scans per day" with the FreeStyle Libre device, and suggest that "devices with automated data transfer may be more suitable in older people with memory problems."
Nonetheless, Mattishent et al found that "participants and caregivers overwhelmingly found using the device acceptable" over 2 weeks of use, with the majority saying that it was unobtrusive and did not interfere with daily activities.
None of the participants reported stress or anxiety related to CGM, while many said they were not aware of the device at night, and the most frequently described advantage was a reduced requirement for finger-prick tests.
The researchers note that their study had a number of limitations, including difficulties recruiting participants in the hospital setting and challenges in study retention, with five of the original 17 participants withdrawing from the study before recording CGM data because they or their caregivers felt it would be overwhelming.
The team concludes: "There is a clear need for a large-scale prospective study using CGM to assess its true potential impact in this vulnerable group."
Original article was published in 11-25-2019 | Diabetes | News | Article.
3.
Useful Links
Frequently
Asked Questions & Answers
EZorb
Clinical Studies
Marvlix
Benefits
Order
Now
4.
Calcium
Absorption Test
EZorb
Calcium has set a new world record of absorption rate.
You can compare EZorb with other calcium supplements
by using the simple step-by-step instructions we
provide. E-mail your request to test @ elixirindustry.com
for a copy of the instructions.
5.
What Are Others Saying About EZorb and Marvlix?
EZorb and Marvlix have restored confidence in thousands of men
and women. It has brought happiness and healthy life
to families around the world. Click here
to read what people say about EZorb and Marvlix. |
